MARATTO

article · Misurata Medical Sciences Journal

EXPRESSION OF EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) AS A BIOMARKER IN ORAL SQUAMOUS CELL CARCINOMA (OSCC)

2025Open accessAlexandria University

Abstract

EMMPRIN is a widely distributed cell surface glycoprotein that belongs to immunoglobulin (Ig) super family. It isinducing the production of extracellular matrix metalloproteinase (MMP) enzymes and play important role in angiogenesis via stimulation of vascular endothelial growth factor (VEGF). The aim of the present work is to evaluate andasses the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in oral squamous cell carcinomasand to compare the expression of extracellular matrix metalloproteinase inducer (EMMPRIN) in different types oforal squamous cell carcinomas. Thirty diagnosed cases of Oral squamous cell carcinoma (OSCC) were selected andimmunohistochemistry was performed for EMMPRIN. All cases showed positive EMMPRIN expression with different intensity. This study concluded that the elevated expression of EMMPRIN levels correlate with tumor proliferation, angiogenesis, metastasis and invasion.

Research topics

  • Signaling Pathways in Disease

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.36602/mmsj/2021.n07.02

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.